High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Aura Biosciences
University of Michigan Rogel Cancer Center
Duke University
Oslo University Hospital
Hospital Universitario Virgen de la Arrixaca
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC